Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionOral insulin analog
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type I and Type II diabetes
Regulatory Designation
PartnerMerrion Pharmaceuticals plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today